Blue Fin Capital, Inc. Merck & Co., Inc. Transaction History

Blue Fin Capital, Inc.

$445 Million
Q1 2024

A detailed history of Blue Fin Capital, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 30,733 shares of MRK stock, worth $3.93 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

30,733

Previous 31,288 1.77%

Holding current value

$3.93 Million

Previous $3.41 Million 18.88%

% of portfolio

0.91%

Previous 0.88%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $62,848 - $73,232	-555 Reduced 1.77%	30,733 $4.06 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $16,730 - $18,206	-167 Reduced 0.53%	31,288 $3.41 Million
Q3 2023 Oct 19, 2023	BUY	$102.95 - $114.33 $17,501 - $19,436	170 Added 0.54%	31,455 $3.24 Million
Q2 2023 Jul 31, 2023	BUY	$108.61 - $118.38 $217 - $236	2 Added 0.01%	31,285 $3.61 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $8,955 - $9,992	87 Added 0.28%	31,283 $3.33 Million

Q4 2022 Jan 23, 2023	BUY	$87.44 - $112.11 $6,383 - $8,184	73 Added 0.23%	31,196 $0
Q3 2022 Nov 04, 2022	BUY	$84.53 - $94.96 $104,986 - $117,940	1,242 Added 4.16%	31,123 $2.68 Million
Q2 2022 Aug 08, 2022	BUY	$83.49 - $94.64 $3,089 - $3,501	37 Added 0.12%	29,881 $2.72 Million
Q1 2022 Apr 12, 2022	BUY	$73.51 - $82.4 $10,364 - $11,618	141 Added 0.47%	29,844 $2.45 Million
Q4 2021 Jan 19, 2022	SELL	$72.28 - $90.54 $33,176 - $41,557	-459 Reduced 1.52%	29,703 $2.28 Million
Q3 2021 Oct 25, 2021	SELL	$71.68 - $78.83 $12,687 - $13,952	-177 Reduced 0.58%	30,162 $2.27 Million
Q2 2021 Jul 19, 2021	BUY	$70.31 - $77.77 $2,742 - $3,033	39 Added 0.13%	30,339 $2.36 Million
Q1 2021 May 05, 2021	BUY	$68.86 - $81.11 $8,814 - $10,382	128 Added 0.42%	30,300 $2.34 Million
Q4 2020 Jan 28, 2021	BUY	$71.77 - $79.65 $45,932 - $50,976	640 Added 2.17%	30,172 $2.47 Million
Q3 2020 Oct 28, 2020	BUY	$73.18 - $82.95 $16,026 - $18,166	219 Added 0.75%	29,532 $2.45 Million
Q2 2020 Aug 10, 2020	BUY	$70.42 - $80.13 $33,097 - $37,661	470 Added 1.63%	29,313 $2.27 Million
Q1 2020 Apr 28, 2020	SELL	$63.36 - $87.82 $18,881 - $26,170	-298 Reduced 1.02%	28,843 $2.22 Million
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $61,986 - $69,944	799 Added 2.82%	29,141 $2.65 Million
Q3 2019 Nov 07, 2019	SELL	$76.08 - $82.93 $131,618 - $143,468	-1,730 Reduced 5.75%	28,342 $2.39 Million
Q2 2019 Jul 22, 2019	BUY	$69.84 - $81.59 $12,431 - $14,523	178 Added 0.6%	30,072 $2.52 Million
Q1 2019 Apr 23, 2019	SELL	$69.58 - $79.36 $32,633 - $37,219	-469 Reduced 1.54%	29,894 $2.49 Million
Q4 2018 Jan 16, 2019	BUY	$65.24 - $75.71 $8,676 - $10,069	133 Added 0.44%	30,363 $2.32 Million
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $10,672 - $12,550	-185 Reduced 0.61%	30,230 $2.15 Million
Q2 2018 Aug 06, 2018	BUY	$50.83 - $59.72 $68,976 - $81,040	1,357 Added 4.67%	30,415 $1.85 Million
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $146,000 - $169,693	2,865 Added 10.94%	29,058 $1.58 Million
Q4 2017 Jan 26, 2018	SELL	$51.62 - $61.64 $103,756 - $123,896	-2,010 Reduced 7.13%	26,193 $1.47 Million
Q3 2017 Oct 11, 2017	BUY	$58.67 - $63.13 $1.65 Million - $1.78 Million	28,203	28,203 $1.81 Million

Others Institutions Holding MRK

# of Institutions

3,767

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $324B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Fin Capital, Inc. with notifications on news.

Account

Blue Fin Capital, Inc. Merck & Co., Inc. Transaction History